These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15812644)

  • 1. [ABO blood group expression in corneal allograft failures].
    Ardjomand N; Komericki P; Klein A; Mattes D; El-Shabrawi Y; Radner H
    Ophthalmologe; 2005 Oct; 102(10):981-6. PubMed ID: 15812644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of blood group antigens A and/or B in diseased corneas.
    Ardjomand N; Reich ME; Radner H
    Curr Eye Res; 1998 Jun; 17(6):650-5. PubMed ID: 9663855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO antigen blood-group compatibility in corneal transplantation.
    Borderie VM; Lopez M; Vedie F; Laroche L
    Cornea; 1997 Jan; 16(1):1-6. PubMed ID: 8985625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ABO blood group, hematopoietic, and other cell-specific antigens by cells in the human cornea.
    Treseler PA; Foulks GN; Sanfilippo F
    Cornea; 1985-1986; 4(3):157-68. PubMed ID: 3916388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group.
    Arch Ophthalmol; 1992 Oct; 110(10):1392-403. PubMed ID: 1417537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
    Hargrave SL; Mayhew E; Hegde S; Niederkorn J
    Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA antigenicity of normal and pathological corneas].
    Delbosc B; Fellmann D; Piquot X; Montard M; Royer J
    J Fr Ophtalmol; 1990; 13(11-12):535-41. PubMed ID: 2081843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of histocompatibility matching in high-risk corneal transplantation: a summary of results from the Collaborative Corneal Transplantation Studies.
    Fink N; Stark WJ; Maguire MG; Stulting D; Meyer R; Foulks G; Smith RE; Rapoza P
    Cesk Oftalmol; 1994 Feb; 50(1):3-12. PubMed ID: 8137435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO antigen blood-group compatibility and allograft rejection in corneal transplantation.
    Inoue K; Tsuru T
    Acta Ophthalmol Scand; 1999 Oct; 77(5):495-9. PubMed ID: 10551286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ABO and Lewis blood group antigens in donor-recipient compatibility of corneal transplantation rejection.
    Roy R; Des Marchais B; Bazin R; Boisjoly HM; Dubé I; Laughrea PA
    Ophthalmology; 1997 Mar; 104(3):508-12. PubMed ID: 9082281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
    Stuart PM; Griffith TS; Usui N; Pepose J; Yu X; Ferguson TA
    J Clin Invest; 1997 Feb; 99(3):396-402. PubMed ID: 9022072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of donor storage time on corneal allograft survival.
    Simon M; Fellner P; El-Shabrawi Y; Ardjomand N
    Ophthalmology; 2004 Aug; 111(8):1534-8. PubMed ID: 15288984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.
    Beutelspacher SC; Pillai R; Watson MP; Tan PH; Tsang J; McClure MO; George AJ; Larkin DF
    Eur J Immunol; 2006 Mar; 36(3):690-700. PubMed ID: 16482510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation.
    Sanfilippo F; MacQueen JM; Vaughn WK; Foulks GN
    N Engl J Med; 1986 Jul; 315(1):29-35. PubMed ID: 3520323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO Blood groups and corneal transplantation.
    Allansmith MR; Drell DW; Kajiyama G; Fine M
    Am J Ophthalmol; 1975 Mar; 79(3):493-501. PubMed ID: 1092175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal allograft rejection.
    Friedlander MH
    Refract Corneal Surg; 1991; 7(1):70-2. PubMed ID: 2043550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts.
    Larkin DF; Alexander RA; Cree IA
    Eye (Lond); 1997; 11 ( Pt 1)():68-74. PubMed ID: 9246279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.